Clinical Trial Update: SMART Program Impact on Quality of Life in Inflammatory Bowel Diseases [NA]

View source ↗

Summary

A Mayo Clinic–sponsored clinical trial evaluating the SMART program's impact on quality of life in inflammatory bowel diseases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Inflammatory Bowel Diseases, Stress | NA | Status: TERMINATED